---
abstract: ''
authors:
- Stewart-Lynch, Autumn
category: Case Study
clinical_significance: High
cme_credits: 0.0
doi: ''
evidence_level: ''
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/37725467/
file_path: 2023/09/finerenone-kerendia-for-the-treatment-of-chronic-kidney-dise.md
issue: '3'
keywords:
- Diabetes Mellitus, Type 2
- Humans
- Patients
- Diabetes
- Renal Insufficiency, Chronic
- Naphthyridines
last_updated: '2025-08-09'
mesh_terms:
- Humans
- Diabetes Mellitus, Type 2
- Naphthyridines
- Patients
- Renal Insufficiency, Chronic
original_format: PubMed
pages: 305-306
patient_population: Adults
peer_reviewed: true
pmid: '37725467'
processed_date: '2025-08-09'
publication_date: '2023-09-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 1
source: American family physician
specialties:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Finerenone (Kerendia) for the Treatment of Chronic Kidney Disease in Patients
  With Type 2 Diabetes Mellitus.
topics:
- Diabetes Mellitus
- Endocrinology
- Family Medicine
- Metabolic Disorders
volume: '108'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '37725467'
  title: Finerenone (Kerendia) for the Treatment of Chronic Kidney Disease in Patients
    With Type 2 Diabetes Mellitus.
  authors:
  - last_name: Stewart-Lynch
    fore_name: Autumn
    initials: A
    affiliation: Duquesne University School of Pharmacy, Pittsburgh, Pennsylvania.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '108'
    issue: '3'
  publication_info:
    year: '2023'
    month: 09
    full_date: '2023-09-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Diabetes Mellitus, Type 2
    major_topic: true
    qualifiers:
    - qualifier: complications
      major_topic: false
    - qualifier: drug therapy
      major_topic: false
  - descriptor: Naphthyridines
    major_topic: false
  - descriptor: Patients
    major_topic: false
  - descriptor: Renal Insufficiency, Chronic
    major_topic: true
    qualifiers:
    - qualifier: complications
      major_topic: false
    - qualifier: drug therapy
      major_topic: false
  publication_types: *id001
related_articles:
- pmid: '37725467'
  title: Finerenone (Kerendia) for the Treatment of Chronic Kidney Disease in Patients
    With Type 2 Diabetes Mellitus.
  authors:
  - name: Stewart-Lynch A
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2023 Sep
- pmid: '34544101'
  title: Finerenone (Kerendia) for chronic kidney disease.
  authors: []
  source: Med Lett Drugs Ther
  pubdate: 2021 Aug 23
- pmid: '36651794'
  title: 'In brief: Finerenone (Kerendia) for diabetic kidney disease.'
  authors: []
  source: Med Lett Drugs Ther
  pubdate: 2023 Jan 23
- pmid: '34888636'
  title: Bringing FIDELITY to the estimate of treatment effects of finerenone in chronic
    kidney disease due to type 2 diabetes.
  authors:
  - name: Adamson C
    authtype: Author
    clusterid: ''
  - name: Jhund PS
    authtype: Author
    clusterid: ''
  source: Eur Heart J
  pubdate: 2022 Feb 10
- pmid: '35500259'
  title: In patients with type 2 diabetes and CKD, finerenone improved CV and kidney
    outcomes.
  authors:
  - name: Mayne KJ
    authtype: Author
    clusterid: ''
  - name: Herrington WG
    authtype: Author
    clusterid: ''
  source: Ann Intern Med
  pubdate: 2022 May
---

# Finerenone (Kerendia) for the Treatment of Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus.

**Authors:** Stewart-Lynch, Autumn

**Published in:** American family physician | Vol. 108, No. 3 | 2023-09-01

**Links:** [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/37725467/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Diabetes Mellitus, Endocrinology, Family Medicine, Metabolic Disorders

## MeSH Terms

Humans, Diabetes Mellitus, Type 2, Naphthyridines, Patients, Renal Insufficiency, Chronic

## Article Content

# Finerenone (Kerendia) for the Treatment of Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus.

**Authors:** Stewart-Lynch, Autumn

**Published in:** American family physician | Vol. 108, No. 3 | 2023-09-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/37725467/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Diabetes Mellitus, Endocrinology, Family Medicine, Metabolic Disorders

## MeSH Terms

Humans, Diabetes Mellitus, Type 2, Naphthyridines, Patients, Renal Insufficiency, Chronic

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/37725467/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/37725467/) (reference)

---

*Processed: 2025-08-09* | *PubMed Enhanced: 2025-07-30*
